Investment Recovery Risk in the Hydrogen Water Business
First written in FY2016-Q3. 3 of 8 entries say "Materialised", first in FY2017. Latest entry: FY2022.
Abist moved to the "Worse" side of this theme in 2022, 1 year before the typical company in this theme (2023).
The whole theme swung hardest in 2025: 15 of 49 companies on the "Worse" side.
68 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「If direct sales to consumers or OEM sales to businesses do not progress as planned, the Group may be unable to recover its investment related to factory construction and other items, which could affect its business results and financial condition.」
The Company continues to disclose the investment recovery risk if direct sales or OEM sales in the beauty and health products manufacturing and sales business do not progress as planned. - FY2022-Q3MaterialisedAnnual report
「These losses consist of product recall costs and other expenses arising from quality nonconformities in some products delivered by the consolidated subsidiary, as well as losses relating to assets expected to become idle. The breakdown was product recall costs of ¥48.573 million, impairment losses on property, plant and equipment of ¥54.880 million, and other expenses of ¥18.573 million.」
In the beauty and health products manufacturing and sales business, product recalls due to quality nonconformities and impairment of idle assets occurred, and the Company recorded ¥122.027 million in losses related to subsidiaries. - FY2022-Q2MaterialisedAnnual report
「For idle assets with no expected future use, the Company determines whether there are indications of impairment for each individual asset. It reduces the carrying amounts of these idle assets to their recoverable amounts and records the decreases within “losses related to subsidiaries.” Recoverable amounts are measured using value in use, which is assumed to be zero.」
In the beauty and health products manufacturing and sales business, idle assets with no expected future use arose, and the Company recorded an impairment loss of ¥54.880 million on buildings, machinery and equipment, and software, with the recoverable amount set at zero. - FY2021RestatedAnnual report
「If direct sales to consumers or OEM sales to businesses do not progress as planned, the Group may be unable to recover its investment related to factory construction and other items, which could affect its business results and financial condition.」
The Company continues to disclose the investment recovery risk if direct sales or OEM sales in the beauty and health products manufacturing and sales business do not progress as planned. - FY2018RestatedAnnual report
「If direct sales to consumers or OEM sales to businesses do not progress as planned, the Group may be unable to recover its investment related to factory construction and other items, which could affect its business results and financial condition.」
The Company continues to disclose, without specifying an amount, the investment recovery risk if direct sales or OEM sales of hydrogen water do not progress as planned. - FY2017MaterialisedAnnual report
「Because the Company determined that recovery of the investment could not be expected within the economically estimated remaining useful life, it reduced the carrying amount of the asset group to its recoverable amount and recorded the decrease, ¥98.571 million, as an impairment loss included in extraordinary losses.」
For the hydrogen-water manufacturing and sales business, the Company determined that recovery of the investment could not be expected and recorded an impairment loss of ¥98.571 million. - FY2016SoftenedAnnual report
「If direct sales to consumers or OEM sales to businesses do not progress as planned, the Group may be unable to recover its investment related to factory construction and other items, which could affect its business results and financial condition.」
The investment recovery risk continued to be disclosed, but the previously stated amount of approximately ¥600 million was not included. - FY2016-Q3First statedAnnual report
「If direct sales to consumers or OEM sales to businesses do not progress as planned, the Group may be unable to recover approximately ¥600 million of investment related to factory construction and other items, which could affect its business results and financial condition.」
The Company explicitly identifies the risk that approximately ¥600 million of investment funds may not be recovered if sales do not progress as planned.